Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW

BACKGROUND: To review treatment outcomes from real-world data of patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) injection. METHODS: RAINBOW (ClinicalTrials.gov, NCT02279537) is an ongoing, observational, 4-year study to monitor the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Michel, Dominguez, Marcel, Coscas, Florence, Faure, Céline, Baillif, Stéphanie, Kodjikian, Laurent, Cohen, Salomon-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249443/
https://www.ncbi.nlm.nih.gov/pubmed/32450838
http://dx.doi.org/10.1186/s12886-020-01468-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249443/
https://www.ncbi.nlm.nih.gov/pubmed/32450838
http://dx.doi.org/10.1186/s12886-020-01468-z

Ejemplares similares